Paul D. Walker

Paul D. Walker

Auto-generated profile, based on publicly available information

Paul D. Walker

School of Chemistry University of Bristol Bristol BS8 1TS UK

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Cell Reports
Verified
Journal Article
Open access
RWRebecca L. Westbrook
Rebecca L. Westbrook
EBEsther Bridges
Esther Bridges
JRJennie Roberts
Jennie Roberts
CECristina Escribano-Gonzalez
Cristina Escribano-Gonzalez
KEKatherine L. Eales
Katherine L. Eales
DTDaniel A. Tennant
Daniel A. Tennant
The demands of cancer cell proliferation alongside an inadequate angiogenic response lead to insufficient oxygen availability in the tumor microenvironment. Within the mitochondria, oxygen is the major electron acceptor for NADH, with the result that the reducing potential produced through tricarboxylic acid (TCA) cycle activity and mitochondrial respiration are functionally linked. As the oxidizing activity of the TCA cycle is required for efficient synthesis of anabolic precursors, tumoral hypoxia could lead to a cessation of proliferation without another means of correcting the redox imbalance. We show that in hypoxic conditions, mitochondrial pyrroline 5-carboxylate reductase 1 (PYCR1) activity is increased, oxidizing NADH with the synthesis of proline as a by-product. We further show that PYCR1 activity is required for the successful maintenance of hypoxic regions by permitting continued TCA cycle activity, and that its loss leads to significantly increased hypoxia in vivo and in 3D culture, resulting in widespread cell death.

15 October 2020 in Natural Product Reports
Verified
Journal Article
Open access
PDF file
PWP. D. Walker
P. D. Walker
AWA. N. M. Weir
A. N. M. Weir
CWChris Willis
Chris Willis
MCM. P. Crump
M. P. Crump
The structural diversity of newly discovered polyketides continues to grow. This review summarises the range of structures with single and multiple β-branches and the mechanistic details of each catalytic step, covering literature from 2008 to August 2020.

11 July 2017 in Chemical Science
Verified
Journal Article
Open access
PDF file
ITIain R. G. Thistlethwaite
Iain R. G. Thistlethwaite
FBFreya M. Bull
Freya M. Bull
CCChengsen Cui
Chengsen Cui
PWPaul D. Walker
Paul D. Walker
SGShu Shan Gao
Shu Shan Gao
CWChris Willis
Chris Willis
Kalimantacin A and batumin exhibit potent and selective antibiotic activity against Staphylococcus species including MRSA. Both compounds are formed via a hybrid polyketide synthase/non-ribosomal peptide synthetase (PKS-NRPS) biosynthetic pathway and from comparison of the gene clusters it is apparent that batumin from Pseudomonas batumici and kalimantacin from P. fluorescens are the same compound. The linear structure of this unsaturated acid was assigned by spectroscopic methods, but the relative and absolute stereochemistry of the five stereocentres remained unknown. Herein we describe isolation of kalimantacin A and two further metabolites 17,19-diol 2 and 27-descarbomyl hydroxyketone 3 from cultures of P. fluorescens. Their absolute and relative stereochemistries are rigorously determined using a multidisciplinary approach combining natural product degradation and fragment synthesis with bioinformatics and NMR spectroscopy. Diol 2 has the 5R, 15S, 17S, 19R, 26R, 27R configuration and is the immediate biosynthetic precursor of the bioactive kalimantacin A formed by oxidation of the 17-alcohol to the ketone.

11 July 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
PWPaul D. Walker
Paul D. Walker
CWChristopher Williams
Christopher Williams
AWAngus N. M. Weir
Angus N. M. Weir
LWLuoyi Wang
Luoyi Wang
JCJohn Crosby
John Crosby
MCMatthew P. Crump
Matthew P. Crump

1 July 2004 in Synapse
Verified
Journal Article
Closed access
PDF file
CKChristian W. Kreipke
Christian W. Kreipke
PWPaul D. Walker
Paul D. Walker

10 November 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
AWAshley J. Winter
Ashley J. Winter
MRMatthew T. Rowe
Matthew T. Rowe
AWAngus N. M. Weir
Angus N. M. Weir
NANahida Akter
Nahida Akter
SMSbusisiwe Z. Mbatha
Sbusisiwe Z. Mbatha
MCMatthew P. Crump
Matthew P. Crump
Mupirocin is a clinically important antibiotic produced by Pseudomonas fluorescens NCIMB 10586 that is assembled by a complex trans‐AT polyketide synthase. The polyketide fragment, monic acid, is esterified by a 9‐hydroxynonanoic acid (9HN) side chain which is essential for biological activity. The ester side chain assembly is initialised from a 3‐hydroxypropionate (3HP) starter unit attached to the acyl carrier protein (ACP) MacpD, but the fate of this species is unknown. Herein we report the application of NMR spectroscopy, mass spectrometry, chemical probes and in vitro assays to establish the remaining steps of 9HN biosynthesis. These investigations reveal a complex interplay between a novel iterative or “stuttering” KS‐AT didomain (MmpF), the multidomain module MmpB and multiple ACPs. This work has important implications for understanding the late‐stage biosynthetic steps of mupirocin and will be important for future engineering of related trans‐AT biosynthetic pathways (e.g. thiomarinol).